Page 7 - TBE_Book_V2_2019

Priv.-Doz. Dr. Gerhard Dobler,
Bundeswehr Institute of Microbiology, Munich, Germany

Dr. Susanne Dudman,
Norwegian Institute of Public Health, Division for Infection Control and Environmental Health,
Oslo, Norway

B.Sc. Kristin Edgar,
Norwegian Institute of Public Health, Division for Infection Control and Environmental Health,
Oslo, Norway

Dr. Wilhelm Erber,
Director Medical and Scientific Affairs, Pfizer Vaccines, Vienna, Austria

Dr. Maria Esyunina,
Regional Medical Advisor, Vaccines, Pfizer Innovations LLC, Moscow, Russia

Dr. Anders Fomsgaard,
Virus R&D Laboratory, Statens Serum institute, Copenhagen, Denmark
Infectious Disease Research Unit, Clinical Institute, University of Southern Denmark

Dr. Ernest A. Gould,
Aix-Marseille Université, Marseille, France

Dr. Sara Gredmark-Russ,
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet,
Karolinska University Hospital, Stockholm, Sweden

Prof. Dr. Wlodzimierz Gut,
Department of Virology, National Institute of Public Health-NIH (NIPH-NIH), Warsaw, Poland

Prof. Dr. Dr. Martin Haditsch,
Medical Head, Labor Hannover MVZ, Hannover, Germany; TravelMedCenter Leonding, Austria

Dr. Yves Hansmann,
Infectious Disease Department, Strasbourg University Hospital, Strasbourg, France

Prof. Dr. Franz-Xaver Heinz,
Center for Virology, Medical University of Vienna, Austria

Prof. Dr. Heidemarie Holzmann,
Center for Virology, Medical University of Vienna, Austria

Dr. Tabitha Hoornweg,
Dutch National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

2